Central Pacific Bank - Trust Division’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$724K Sell
13,813
-4,997
-27% -$264K 0.07% 252
2026
Q1
$1.04M Sell
18,810
-2,850
-13% -$154K 0.13% 166
2025
Q4
$1.06M Sell
21,660
-2,950
-12% -$138K 0.13% 162
2025
Q3
$1.06M Sell
24,610
-100
-0.4% -$3.91K 0.13% 168
2025
Q2
$949K Buy
24,710
+300
+1% +$11.5K 0.12% 180
2025
Q1
$946K Buy
24,410
+2,361
+11% +$86.4K 0.13% 158
2024
Q4
$746K Sell
22,049
-300
-1% -$10.8K 0.1% 202
2024
Q3
$914K Sell
22,349
-200
-0.9% -$8.18K 0.12% 191
2024
Q2
$868K Hold
22,549
0.1% 205
2024
Q1
$957K Buy
+22,549
New +$930K 0.12% 191

Other funds holding GSK

Central Pacific Bank - Trust Division's GSK Position: Q2 2026 in Review

Central Pacific Bank - Trust Division reduced its GSK (GSK) stake by 27% in Q2 2026, selling an estimated $264K and leaving 13,813 shares worth $724K. The position accounts for 0.07% of the portfolio, ranked #252.

Central Pacific Bank - Trust Division first reported a position in GSK in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.06M in Q4 2025. 296 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Central Pacific Bank - Trust Division held 13,813 shares of GSK worth $724K as of Q2 2026.
  • Central Pacific Bank - Trust Division sold 4,997 GSK shares in Q2 2026, an estimated $264K.
  • GSK made up 0.07% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #252 holding.
  • Central Pacific Bank - Trust Division first reported a position in GSK in Q1 2024 and has held it in 10 quarters since.
  • Central Pacific Bank - Trust Division's GSK position peaked at $1.06M in Q4 2025.
  • 296 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.